Cargando…

Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan

PURPOSE: The development and production of novel vaccine to prevent COVID-19 is an international imperative to human lives. For that purpose, clinical trials have to be carried out as per international ethical standards. The current study was undertaken to examine the willingness to participate in C...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Farha, Rana K, Alzoubi, Karem H, Khabour, Omar F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754261/
https://www.ncbi.nlm.nih.gov/pubmed/33363361
http://dx.doi.org/10.2147/PPA.S284385
_version_ 1783626154412867584
author Abu-Farha, Rana K
Alzoubi, Karem H
Khabour, Omar F
author_facet Abu-Farha, Rana K
Alzoubi, Karem H
Khabour, Omar F
author_sort Abu-Farha, Rana K
collection PubMed
description PURPOSE: The development and production of novel vaccine to prevent COVID-19 is an international imperative to human lives. For that purpose, clinical trials have to be carried out as per international ethical standards. The current study was undertaken to examine the willingness to participate in COVID-19 vaccine clinical trials and to determine factors that might affect their decision to participate. PATIENTS AND METHODS: A cross-sectional survey study was carried out among the public in Jordan. During the study period, a convenience sample of adults (aged 18 years or above) were asked to participate via an online self-administered survey that was designed to evaluate the willingness to participate in COVID-19 vaccine clinical trials and to determine factors affecting their decision to participate. RESULTS: Results showed that, among participants (n=1,287), 36.1% reported to be willing to participate in clinical trials of the vaccine. Additionally, a lower percentage (18.1%) were willing to allow their children to participate. Motivators that encourage participation were the desire to return to normal life (73.2%), followed by the desire to help in finding a treatment for COVID-19 infection (68.1%). Barriers towards the participation were not wanting to be challenged by the virus (54.7%), fear (40.7%), lack of time (40.4%), and mistrust in pharmaceutical companies (38.9%). Finally, results showed that higher educational level was associated with lower willingness to participate (P=0.001), whereas having a previous participation in clinical studies is associated with a significantly higher willingness to participate in COVID-19 vaccine clinical trials (P<0.001). CONCLUSION: A good portion of Jordanians are positive regarding participation in clinical studies of COVID-19 vaccine. Educational level and previous participation in clinical studies were among the determinants of such willingness. In addition, fear and lack of time were among the barriers of participation.
format Online
Article
Text
id pubmed-7754261
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77542612020-12-23 Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan Abu-Farha, Rana K Alzoubi, Karem H Khabour, Omar F Patient Prefer Adherence Original Research PURPOSE: The development and production of novel vaccine to prevent COVID-19 is an international imperative to human lives. For that purpose, clinical trials have to be carried out as per international ethical standards. The current study was undertaken to examine the willingness to participate in COVID-19 vaccine clinical trials and to determine factors that might affect their decision to participate. PATIENTS AND METHODS: A cross-sectional survey study was carried out among the public in Jordan. During the study period, a convenience sample of adults (aged 18 years or above) were asked to participate via an online self-administered survey that was designed to evaluate the willingness to participate in COVID-19 vaccine clinical trials and to determine factors affecting their decision to participate. RESULTS: Results showed that, among participants (n=1,287), 36.1% reported to be willing to participate in clinical trials of the vaccine. Additionally, a lower percentage (18.1%) were willing to allow their children to participate. Motivators that encourage participation were the desire to return to normal life (73.2%), followed by the desire to help in finding a treatment for COVID-19 infection (68.1%). Barriers towards the participation were not wanting to be challenged by the virus (54.7%), fear (40.7%), lack of time (40.4%), and mistrust in pharmaceutical companies (38.9%). Finally, results showed that higher educational level was associated with lower willingness to participate (P=0.001), whereas having a previous participation in clinical studies is associated with a significantly higher willingness to participate in COVID-19 vaccine clinical trials (P<0.001). CONCLUSION: A good portion of Jordanians are positive regarding participation in clinical studies of COVID-19 vaccine. Educational level and previous participation in clinical studies were among the determinants of such willingness. In addition, fear and lack of time were among the barriers of participation. Dove 2020-12-14 /pmc/articles/PMC7754261/ /pubmed/33363361 http://dx.doi.org/10.2147/PPA.S284385 Text en © 2020 Abu-Farha et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Abu-Farha, Rana K
Alzoubi, Karem H
Khabour, Omar F
Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan
title Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan
title_full Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan
title_fullStr Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan
title_full_unstemmed Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan
title_short Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan
title_sort public willingness to participate in covid-19 vaccine clinical trials: a study from jordan
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754261/
https://www.ncbi.nlm.nih.gov/pubmed/33363361
http://dx.doi.org/10.2147/PPA.S284385
work_keys_str_mv AT abufarharanak publicwillingnesstoparticipateincovid19vaccineclinicaltrialsastudyfromjordan
AT alzoubikaremh publicwillingnesstoparticipateincovid19vaccineclinicaltrialsastudyfromjordan
AT khabouromarf publicwillingnesstoparticipateincovid19vaccineclinicaltrialsastudyfromjordan